ABYAX | LOTAX | ABYAX / LOTAX | |
Total Expense Ratio | 2.04 | 2.02 | 101% |
Annual Report Gross Expense Ratio | 2.10 | 2.02 | 104% |
Fund Existence | 11 years | 11 years | - |
Gain YTD | -3.923 | -4.288 | 91% |
Front Load | 6% | 6% | 100% |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.33B | 285M | 817% |
Annual Yield % from dividends | 1.76 | 5.14 | 34% |
Returns for 1 year | -3.79 | -3.95 | 96% |
Returns for 3 years | -14.16 | -23.12 | 61% |
Returns for 5 years | 9.41 | 9.18 | 102% |
Returns for 10 years | 7.17 | 2.19 | 328% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PWETX | 16.20 | 0.22 | +1.38% |
PACE International Em Mkts Eq P2 | |||
BGEZX | 10.84 | 0.12 | +1.12% |
Baillie Gifford Emer Mkt Ex Chn K | |||
PHLCX | 12.48 | 0.10 | +0.81% |
PGIM Jennison Health Sciences C | |||
GMVRX | 16.75 | 0.08 | +0.48% |
Goldman Sachs Small/Mid Cap Equity R | |||
FKACX | 34.34 | -0.01 | -0.03% |
Franklin Growth Opportunities C |